THERAPEUTIC EDUCATION of SEXUAL DYSFUNCTIONS in WOMEN SURVIVORS of SEXUAL VIOLENCE and FEMALE GENITAL MUTILATION

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorUniversity of Alcala

About this trial

Violence against women is a problem that affects women all over the planet, causing physical, emotional, and other repercussions for its survivors. Pelvic floor dysfunctions, especially female sexual dysfunctions, are among the most common physical consequences for women who have suffered sexual violence or female genital mutilation. Pelvic floor physiotherapy is the first-line treatment for these dysfunctions, with therapeutic education being one of its main strategies due to its importance in the cognitive approach and for promoting patient adherence to the proposed treatments. Women who are survivors of sexual violence and female genital mutilation, being at risk for these disorders, express the need to receive information about these dysfunctions and their possible treatments. However, it has been shown that their knowledge in this regard is limited. Therefore, a project is proposed with the objective of determining the effectiveness of an intervention based on therapeutic education in the prevention and management of sexual dysfunctions secondary to sexual violence or female genital mutilation. A group educational program is proposed, which allows survivor women to address these dysfunctions in a non-invasive way. Six sessions are planned to promote the development of various competencies: communicating their needs, integrating knowledge about their health problem, identifying and analyzing, decision-making and know-how, problem-solving, using healthcare resources and asserting their rights. This will provide these women a safe space to share their experiences, learn to manage them, acquire knowledge about the pelvic floor, related dysfunctions and their treatment, as well as self-efficacy tools for dealing with sexual dysfunctions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 and older

No severe psychiatric disorders or any other condition that prevents them from answering questions and questionnaires

Emotionally prepared to address the affected physical and sexual sphere

Aged 18 and older

Disqualifiers

Women who have suffered sexual assaults in the context of trafficking of women and girls for sexual exploitation.

Women who have difficulty understanding the Spanish language.

Women who are not psychologically prepared to address their sexuality.

Trial design

Design model

Parallel

Treatments tested in this trial

  • THERAPEUTIC EDUCATION IN PHYSIOTHERAPY

    Behavioral

    Educational program of physiotherapy for women survivors of sexual violence and female genital mutilation.

  • Psychotherapy and legal advice

    Behavioral

    Usual psychological and legal advice therapy for this population

Treatment groups

163 Participants
are divided into 2 treatment groups
Group A: EXPERIMENTALExperimental treatment 2 interventions
Group B: CONTROLActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Female Sexual Function Index

Assessed using the Spanish version of the FSFI. The FSFI is a 19-item questionnaire that evaluates sexual function across six domains: desire, arousal, lubrication, orgasm, satis-faction, and pain. Each domain is scored from 0 to 5, with higher scores indicating better sexual function. The total FSFI score ranges from 2 to 36, with higher scores reflecting improved sexual function.

Time frame
Before intervention (A0); immediately after completing the intervention (A1), and at 3 months (A2), 6 months (A3), and 12 months (A4) following A1.

Secondary outcomes

1

Treatment Satisfaction

Satisfaction with the treatment will be assessed using a numerical verbal scale ranging from 0 to 10, where 0 represents no satisfaction and 10 indicates ex-cellent satisfaction. This evaluation will begin with assessment A1.

Time frame
After completing the intervention (A1), and at 3 months (A2), 6 months (A3), and 12 months (A4) following A1

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: